Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00018-022-04401-3, but it redirected us to https://link.springer.com/article/10.1007/s00018-022-04401-3. The analysis below is for the second page.

Title[redir]:
Contribution of specific ceramides to obesity-associated metabolic diseases | Cellular and Molecular Life Sciences
Description:
Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play specialized regulatory roles in cellular metabolism depending on their characteristic fatty acyl chain lengths and subcellular distribution. As obesity progresses, certain ceramide molecular species accumulate in metabolic tissues and cause cell-type-specific lipotoxic reactions that disrupt metabolic homeostasis and lead to the development of cardiometabolic diseases. Several mechanisms for ceramide action have been inferred from studies in vitro, but only recently have we begun to better understand the acyl chain length specificity of ceramide-mediated signaling in the context of physiology and disease in vivo. New discoveries show that specific ceramides affect various metabolic pathways and that global or tissue-specific reduction in selected ceramide pools in obese rodents is sufficient to improve metabolic health. Here, we review the tissue-specific regulation and functions of ceramides in obesity, thus highlighting the emerging concept of selectively inhibiting production or action of ceramides with specific acyl chain lengths as novel therapeutic strategies to ameliorate obesity-associated diseases.

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We find it hard to spot revenue streams.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

ceramide, pubmed, google, scholar, ceramides, cas, central, insulin, metabolic, obesity, mitochondrial, cell, cers, synthesis, fatty, lipid, effects, mice, resistance, species, muscle, specific, liver, increased, biol, obese, diabetes, cells, content, membrane, metabolism, hepatic, glucose, accumulation, levels, role, chain, inhibition, signaling, homeostasis, tissue, stress, chem, regulation, protein, metab, studies, disease, novo, function,

Topics {✒️}

jnk c-jun-n-terminal kinase long-chain-fatty-acid-coa ligase ceramide-initiated sapk/jnk signalling fa-coa fatty acyl-coenzyme methyl-branched long-chain bases tumor necrosis factor-alpha appetite-regulating agouti-related peptide high-fat diet-fed mice high-fat diet-dependent increase high-fat diet-fed rats c16-ceramide-induced channel formation form ultra-long-chain ceramides c26-coa-dependent ceramide synthesis high-fat diet-fed fixed acyl chain length branched long-chain bases rna-activated protein kinase high-fat diet feeding ceramide acyl-chain length diet-induced mitochondrial fragmentation sphingolipid n-acyl chain cell-type-specific lipotoxic reactions intestinal cers4-dependent ceramide synthesis cell-type-specific adverse reactions asah n-acylsphingosine aminohydrolase cgt ceramide udp-galactosyltransferase vesicle-bound intercellular transfer high-fat diet exposure sphingoid long-chain bases endoplasmic reticulum-mitochondria junction mediates lipid-induced inflammation methionine-choline deficient diet short-term mechanical unloading ceramide-activated protein kinase ceramide-dependent regulatory networks diet-induced insulin resistance chain length-specific properties fatty acid-induced lipotoxicity long-chain sphingolipid species protein-lipid overlay assays palmitate-induced mitochondrial fragmentation tumor necrosis factor ameliorates ceramide-induced lipotoxicity obesity-induced cers6-dependent c16 hypothalamic pgc-1alpha protects diet providing precursor substrates ormdl/orm-serine palmitoyltransferase membrane-emanating signaling cascades developing tissue-restrictive drugs mouse strain-dependent variation

Questions {❓}

  • Amati F et al (2011) Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?
  • Bionda C et al (2004) Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?
  • Is it possible to modulate ceramide metabolism for the treatment of obesity-related diseases?
  • Pewzner-Jung Y, Ben-Dor S, Futerman AH (2006) When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?
  • Summers SA (2018) Could ceramides become the new cholesterol?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Contribution of specific ceramides to obesity-associated metabolic diseases
         description:Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play specialized regulatory roles in cellular metabolism depending on their characteristic fatty acyl chain lengths and subcellular distribution. As obesity progresses, certain ceramide molecular species accumulate in metabolic tissues and cause cell-type-specific lipotoxic reactions that disrupt metabolic homeostasis and lead to the development of cardiometabolic diseases. Several mechanisms for ceramide action have been inferred from studies in vitro, but only recently have we begun to better understand the acyl chain length specificity of ceramide-mediated signaling in the context of physiology and disease in vivo. New discoveries show that specific ceramides affect various metabolic pathways and that global or tissue-specific reduction in selected ceramide pools in obese rodents is sufficient to improve metabolic health. Here, we review the tissue-specific regulation and functions of ceramides in obesity, thus highlighting the emerging concept of selectively inhibiting production or action of ceramides with specific acyl chain lengths as novel therapeutic strategies to ameliorate obesity-associated diseases.
         datePublished:2022-07-05T00:00:00Z
         dateModified:2022-07-05T00:00:00Z
         pageStart:1
         pageEnd:39
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s00018-022-04401-3
         keywords:
            Atherosclerosis
            Ceramide acyl chain length
            Sphingolipids
            Lipid signaling
            Lipotoxicity
            High-fat diet
            Obesity
            Insulin resistance
            Diabetes
            Metabolic disease treatment
            Cell Biology
            Biomedicine
            general
            Life Sciences
            Biochemistry
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04401-3/MediaObjects/18_2022_4401_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04401-3/MediaObjects/18_2022_4401_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04401-3/MediaObjects/18_2022_4401_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04401-3/MediaObjects/18_2022_4401_Fig4_HTML.png
         isPartOf:
            name:Cellular and Molecular Life Sciences
            issn:
               1420-9071
               1420-682X
            volumeNumber:79
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Philipp Hammerschmidt
               affiliation:
                     name:Max Planck Institute for Metabolism Research
                     address:
                        name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
                        type:PostalAddress
                     type:Organization
                     name:University Hospital Cologne
                     address:
                        name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
                     name:University of Cologne
                     address:
                        name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jens C. Brüning
               affiliation:
                     name:Max Planck Institute for Metabolism Research
                     address:
                        name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
                        type:PostalAddress
                     type:Organization
                     name:University Hospital Cologne
                     address:
                        name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
                     name:University of Cologne
                     address:
                        name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
                        type:PostalAddress
                     type:Organization
                     name:National Center for Diabetes Research (DZD)
                     address:
                        name:National Center for Diabetes Research (DZD), Neuherberg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Contribution of specific ceramides to obesity-associated metabolic diseases
      description:Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play specialized regulatory roles in cellular metabolism depending on their characteristic fatty acyl chain lengths and subcellular distribution. As obesity progresses, certain ceramide molecular species accumulate in metabolic tissues and cause cell-type-specific lipotoxic reactions that disrupt metabolic homeostasis and lead to the development of cardiometabolic diseases. Several mechanisms for ceramide action have been inferred from studies in vitro, but only recently have we begun to better understand the acyl chain length specificity of ceramide-mediated signaling in the context of physiology and disease in vivo. New discoveries show that specific ceramides affect various metabolic pathways and that global or tissue-specific reduction in selected ceramide pools in obese rodents is sufficient to improve metabolic health. Here, we review the tissue-specific regulation and functions of ceramides in obesity, thus highlighting the emerging concept of selectively inhibiting production or action of ceramides with specific acyl chain lengths as novel therapeutic strategies to ameliorate obesity-associated diseases.
      datePublished:2022-07-05T00:00:00Z
      dateModified:2022-07-05T00:00:00Z
      pageStart:1
      pageEnd:39
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s00018-022-04401-3
      keywords:
         Atherosclerosis
         Ceramide acyl chain length
         Sphingolipids
         Lipid signaling
         Lipotoxicity
         High-fat diet
         Obesity
         Insulin resistance
         Diabetes
         Metabolic disease treatment
         Cell Biology
         Biomedicine
         general
         Life Sciences
         Biochemistry
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04401-3/MediaObjects/18_2022_4401_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04401-3/MediaObjects/18_2022_4401_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04401-3/MediaObjects/18_2022_4401_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00018-022-04401-3/MediaObjects/18_2022_4401_Fig4_HTML.png
      isPartOf:
         name:Cellular and Molecular Life Sciences
         issn:
            1420-9071
            1420-682X
         volumeNumber:79
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Philipp Hammerschmidt
            affiliation:
                  name:Max Planck Institute for Metabolism Research
                  address:
                     name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
                     type:PostalAddress
                  type:Organization
                  name:University Hospital Cologne
                  address:
                     name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
                  name:University of Cologne
                  address:
                     name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jens C. Brüning
            affiliation:
                  name:Max Planck Institute for Metabolism Research
                  address:
                     name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
                     type:PostalAddress
                  type:Organization
                  name:University Hospital Cologne
                  address:
                     name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
                  name:University of Cologne
                  address:
                     name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
                     type:PostalAddress
                  type:Organization
                  name:National Center for Diabetes Research (DZD)
                  address:
                     name:National Center for Diabetes Research (DZD), Neuherberg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cellular and Molecular Life Sciences
      issn:
         1420-9071
         1420-682X
      volumeNumber:79
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Max Planck Institute for Metabolism Research
      address:
         name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
         type:PostalAddress
      name:University Hospital Cologne
      address:
         name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
         type:PostalAddress
      name:University of Cologne
      address:
         name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
         type:PostalAddress
      name:Max Planck Institute for Metabolism Research
      address:
         name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
         type:PostalAddress
      name:University Hospital Cologne
      address:
         name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
         type:PostalAddress
      name:University of Cologne
      address:
         name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
         type:PostalAddress
      name:National Center for Diabetes Research (DZD)
      address:
         name:National Center for Diabetes Research (DZD), Neuherberg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Philipp Hammerschmidt
      affiliation:
            name:Max Planck Institute for Metabolism Research
            address:
               name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
               type:PostalAddress
            type:Organization
            name:University Hospital Cologne
            address:
               name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
            name:University of Cologne
            address:
               name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
      name:Jens C. Brüning
      affiliation:
            name:Max Planck Institute for Metabolism Research
            address:
               name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
               type:PostalAddress
            type:Organization
            name:University Hospital Cologne
            address:
               name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
            name:University of Cologne
            address:
               name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
               type:PostalAddress
            type:Organization
            name:National Center for Diabetes Research (DZD)
            address:
               name:National Center for Diabetes Research (DZD), Neuherberg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
      name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
      name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
      name:Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Cologne, Germany
      name:Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), University Hospital Cologne, Cologne, Germany
      name:Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
      name:National Center for Diabetes Research (DZD), Neuherberg, Germany

External Links {🔗}(1707)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref
  • Pbgrd

7.38s.